{"date":"2026-08-10","count":83,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-8436-2026-08-10-2042-3rs79g","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"20:42:16","subject":"公告本公司董事會決議向關係人取得不動產","clause":"第20款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-08-10 20:42，「公告本公司董事會決議向關係人取得不動產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-08-10-2041-1n58kym","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"20:41:20","subject":"公告本公司董事會決議通過現金增資TCI BIOTECH USA LLC案","clause":"第20款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-08-10 20:41，「公告本公司董事會決議通過現金增資TCI BIOTECH USA LLC案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-08-10-2040-1h3ceio","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"20:40:55","subject":"公告本公司董事會決議買回庫藏股","clause":"第35款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-08-10 20:40，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-08-10-2016-1akoapa","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"20:16:42","subject":"公告本公司提報董事會2026年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-08-10 20:16，「公告本公司提報董事會2026年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-08-10-1926-w3y9on","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"19:26:03","subject":"本公司之部份資訊系統遭受駭客網路攻擊","clause":"第26款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-08-10 19:26，「本公司之部份資訊系統遭受駭客網路攻擊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2026-08-10-1914-1akoapa","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"19:14:15","subject":"公告本公司提報董事會2026年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2026-08-10 19:14，「公告本公司提報董事會2026年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-08-10-1902-5j9o7v","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"19:02:31","subject":"公告本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-08-10 19:02，「公告本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-08-10-1853-1k1fn72","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"18:53:29","subject":"公告本公司第二屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-08-10 18:53，「公告本公司第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-08-10-1838-1xzo7rd","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"18:38:43","subject":"公告本公司董事會通過115年第二季個別財務報告","clause":"第43款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-08-10 18:38，「公告本公司董事會通過115年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-08-10-1827-1f7epnq","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"18:27:14","subject":"公告本公司董事會委任薪資報酬委員會第二屆委員","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-08-10 18:27，「公告本公司董事會委任薪資報酬委員會第二屆委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2026-08-10-1825-11n77xt","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"18:25:44","subject":"公告本公司董事會通過民國115年第二季個別財務報告","clause":"第43款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2026-08-10 18:25，「公告本公司董事會通過民國115年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-08-10-1823-14ji2tz","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:23:17","subject":"公告本公司第五屆薪資報酬委員會召集人","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-08-10 18:23，「公告本公司第五屆薪資報酬委員會召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-08-10-1822-few5v1","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:22:35","subject":"公告本公司第三屆審計委員會召集人","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-08-10 18:22，「公告本公司第三屆審計委員會召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-08-10-1821-37n2dy","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:21:34","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-08-10 18:21，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-08-10-1820-sn763a","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:20:43","subject":"公告本公司董事會決議通過115年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-08-10 18:20，「公告本公司董事會決議通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-08-10-1813-1mfjszp","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"18:13:06","subject":"代重要子公司SUNETIC BIOTECH INC.公告董事辭任","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-08-10 18:13，「代重要子公司SUNETIC BIOTECH INC.公告董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-08-10-1812-19t9tyy","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"18:12:39","subject":"代重要子公司SUNETIC BIOTECH INC.公告董事長辭任","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-08-10 18:12，「代重要子公司SUNETIC BIOTECH INC.公告董事長辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-08-10-1812-1vpjbxf","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"18:12:14","subject":"公告本公司董事會決議除權基準日","clause":"第14款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-08-10 18:12，「公告本公司董事會決議除權基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-08-10-1811-1uugkqo","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"18:11:31","subject":"本公司董事會決議通過115年第2季合併財務報告案","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-08-10 18:11，「本公司董事會決議通過115年第2季合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-08-10-1811-s0kpz3","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"18:11:17","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-08-10 18:11，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-08-10-1809-tu4msi","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:09:17","subject":"公告本公司與安美得生醫股份有限公司簽訂長效止痛針劑東南亞市場授權增補協議","clause":"第10款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-08-10 18:09，「公告本公司與安美得生醫股份有限公司簽訂長效止痛針劑東南亞市場授權增補協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-08-10-1808-fkwkas","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:08:58","subject":"公告本公司董事會通過解除與巴基斯坦AJM Pharma簽署之「LT1001巴基斯坦專屬授權合約」","clause":"第10款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-08-10 18:08，「公告本公司董事會通過解除與巴基斯坦AJM Pharma簽署之「LT1001巴基斯坦專屬授權合約」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-08-10-1808-j4oxnm","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:08:33","subject":"公告本公司董事會通過與烏克蘭Darnytsia藥廠終止LT1001長效止痛針劑烏克蘭「獨家授權經銷合約」","clause":"第10款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-08-10 18:08，「公告本公司董事會通過與烏克蘭Darnytsia藥廠終止LT1001長效止痛針劑烏克蘭「獨家授權經銷合約」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-08-10-1807-4c8ete","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:07:23","subject":"本公司董事會通過115年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-08-10 18:07，「本公司董事會通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-08-10-1801-zygqe0","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:01:56","subject":"公告本公司董事會決議委任第五屆薪酬委員會委員","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-08-10 18:01，「公告本公司董事會決議委任第五屆薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-08-10-1801-4mya1d","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:01:42","subject":"公告本公司董事會通過115年第2季財務報表","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-08-10 18:01，「公告本公司董事會通過115年第2季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-08-10-1801-1moaz6h","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"18:01:12","subject":"依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第三款公告及第四款公告","clause":"第22款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-08-10 18:01，「依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第三款公告及第四款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-08-10-1754-1c4nmbw","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:54:28","subject":"公告本公司董事會決議委任永續發展暨風險管理委員會委員","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-08-10 17:54，「公告本公司董事會決議委任永續發展暨風險管理委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-08-10-1754-104bnbb","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:54:08","subject":"代孫公司艾司博迪亞(上海)生物科技有限公司公告研發中之ADC新藥ACE723向中國NMPA提出人體臨床試驗審查申請。","clause":"第8款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-08-10 17:54，「代孫公司艾司博迪亞(上海)生物科技有限公司公告研發中之ADC新藥ACE723向中國NMPA提出人體臨床試驗審查申請。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-08-10-1752-wuc4cw","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:52:48","subject":"公告本公司董事會通過股東現金股利配息基準日","clause":"第14款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-08-10 17:52，「公告本公司董事會通過股東現金股利配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-08-10-1752-17qvvm5","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:52:21","subject":"公告本公司董事會通過115年第二季財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-08-10 17:52，「公告本公司董事會通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-08-10-1750-b6c4zx","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:50:25","subject":"公告本公司董事會通過115年Q2個別財務報告","clause":"第43款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-08-10 17:50，「公告本公司董事會通過115年Q2個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-08-10-1750-1hyqj0c","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:50:21","subject":"公告本公司董事會通過115年第2季合併財報務告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-08-10 17:50，「公告本公司董事會通過115年第2季合併財報務告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-08-10-1735-1x66lda","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:35:20","subject":"本公司董事會決議第二季不分派股利","clause":"第14款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-08-10 17:35，「本公司董事會決議第二季不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-08-10-1731-1cesth6","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:31:37","subject":"公告本公司115年7月份自結合併損益","clause":"第53款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-08-10 17:31，「公告本公司115年7月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-08-10-1730-37n2dy","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:30:14","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-08-10 17:30，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-08-10-1728-37n2dy","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:28:53","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-08-10 17:28，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-08-10-1728-1egfkms","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:28:17","subject":"公告本公司董事會通過重要決議","clause":"第53款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-08-10 17:28，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-08-10-1722-xo2pc7","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:22:59","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第9款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-08-10 17:22，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-08-10-1722-drgvb6","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:22:33","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-08-10 17:22，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-08-10-1722-1xzo7rd","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:22:08","subject":"公告本公司董事會通過115年第二季個別財務報告","clause":"第43款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-08-10 17:22，「公告本公司董事會通過115年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-08-10-1714-1k1fn72","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:14:01","subject":"公告本公司第二屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-08-10 17:14，「公告本公司第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-08-10-1711-1mz8cll","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"17:11:41","subject":"本公司新藥CBL-514注射劑之第二個多國多中心樞紐三期臨床試驗CBL-0302的計畫書變更申請，今日已取得澳洲主管機關HREC核准執行。","clause":"第10款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-08-10 17:11，「本公司新藥CBL-514注射劑之第二個多國多中心樞紐三期臨床試驗CBL-0302的計畫書變更申請，今日已取得澳洲主管機關」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-08-10-1711-nn5qfz","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:11:05","subject":"本公司董事會決議通過115年第2季財務報告","clause":"第43款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-08-10 17:11，「本公司董事會決議通過115年第2季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-08-10-1709-puuep8","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:09:02","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告","clause":"第23款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-08-10 17:09，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-08-10-1708-8dvog5","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:08:44","subject":"公告本公司研發主管及代理發言人異動","clause":"第8款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-08-10 17:08，「公告本公司研發主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-08-10-1708-37n2dy","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"17:08:23","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-08-10 17:08，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-08-10-1707-37n2dy","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:07:33","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-08-10 17:07，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-08-10-1706-6zb90s","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:06:07","subject":"公告本公司董事會通過115年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-08-10 17:06，「公告本公司董事會通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-08-10-1704-s3fqjw","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:04:49","subject":"公告本公司董事會決議通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-08-10 17:04，「公告本公司董事會決議通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-08-10-1704-57zjbn","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"17:04:29","subject":"公告本公司副總經理異動","clause":"第8款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-08-10 17:04，「公告本公司副總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-08-10-1702-5rax5d","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:02:18","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-08-10 17:02，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-08-10-1701-1xkpihx","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:01:55","subject":"公告本公司115年第二季合併財務報告業經提報董事會通過","clause":"第43款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-08-10 17:01，「公告本公司115年第二季合併財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-08-10-1700-1vekemf","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"17:00:54","subject":"本公司董事會通過115年第二季財務報告","clause":"第43款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-08-10 17:00，「本公司董事會通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-08-10-1629-5rax5d","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"16:29:49","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-08-10 16:29，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-08-10-1629-100esni","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"16:29:11","subject":"公告本公司研發主管異動","clause":"第11款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-08-10 16:29，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-08-10-1628-11n77xt","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"16:28:23","subject":"公告本公司董事會通過民國115年第二季個別財務報告","clause":"第43款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-08-10 16:28，「公告本公司董事會通過民國115年第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-08-10-1621-1e52kxr","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"16:21:26","subject":"公告本公司董事會決議將「薪資報酬委員會」及「提名委員會」合併，更名為「薪資報酬暨提名委員會」，同步解散「提名委員會」","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-08-10 16:21，「公告本公司董事會決議將「薪資報酬委員會」及「提名委員會」合併，更名為「薪資報酬暨提名委員會」，同步解散「提名委員會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-08-10-1613-1btul9r","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"16:13:29","subject":"公告台灣神隆股份有限公司舉行115年上半年線上法人說明會","clause":"第12款","fact_date":"2026-08-17","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-08-10 16:13，「公告台灣神隆股份有限公司舉行115年上半年線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-08-10-1611-1eowrfm","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"16:11:42","subject":"代重要子公司優品生醫股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告","clause":"第23款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-08-10 16:11，「代重要子公司優品生醫股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-08-10-1609-o44k49","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"16:09:26","subject":"本公司申請之治療糖尿病潰瘍方法「Use of adenine inpreparation of drug for treating diabetic ulcers」通過美國國家階段發明專利核准","clause":"第51款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-08-10 16:09，「本公司申請之治療糖尿病潰瘍方法「Use of adenine inpreparation of drug for tre」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-08-10-1608-17qvvm5","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"16:08:40","subject":"公告本公司董事會通過115年第二季財務報告","clause":"第43款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-08-10 16:08，「公告本公司董事會通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-08-10-1608-hcclaf","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"16:08:32","subject":"代重要子公司優品生醫股份有限公司公告決議盈餘分配案","clause":"第14款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-08-10 16:08，「代重要子公司優品生醫股份有限公司公告決議盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-08-10-1604-10qn6yl","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"16:04:56","subject":"公告本公司更換股務代理機構案經集保公司准予備查","clause":"第53款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-08-10 16:04，「公告本公司更換股務代理機構案經集保公司准予備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-08-10-1604-37n2dy","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"16:04:09","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-08-10 16:04，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-08-10-1556-drgvb6","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-08-10","time":"15:56:10","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-08-10 15:56，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-08-10-1538-18wso3s","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"15:38:07","subject":"公告接獲合作夥伴Boryung Biopharma Co.Ltd.通知抗流感病毒新藥 Pixavir marboxil (TG-1000)膠囊獲韓國食品藥物安全部(MFDS)同意進行三期臨床試驗。","clause":"第10款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-08-10 15:38，「公告接獲合作夥伴Boryung Biopharma Co.Ltd.通知抗流感病毒新藥 Pixavir marboxil 」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-08-10-1529-37n2dy","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"15:29:08","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-08-10 15:29，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-08-10-1528-sybsry","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"15:28:57","subject":"公告本公司因會計師事務所內部輪調政策變更簽證會計師","clause":"第7款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-08-10 15:28，「公告本公司因會計師事務所內部輪調政策變更簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-08-10-1528-s0kpz3","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"15:28:21","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-08-10 15:28，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-08-10-1522-vhnjvy","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"15:22:40","subject":"本公司董事會決議註銷限制員工權利新股之減資基準日","clause":"第11款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-08-10 15:22，「本公司董事會決議註銷限制員工權利新股之減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-08-10-1521-isqttc","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"15:21:50","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-08-10 15:21，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2026-08-10-1520-37n2dy","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"15:20:55","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2026-08-10 15:20，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-08-10-1516-1wb87j0","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"15:16:20","subject":"本公司董事會決議辦理115年第1次私募普通股定價相關事宜","clause":"第11款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-08-10 15:16，「本公司董事會決議辦理115年第1次私募普通股定價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-08-10-1513-j0iylv","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"15:13:21","subject":"公告本公司訂定除權基準日及相關事宜","clause":"第14款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-08-10 15:13，「公告本公司訂定除權基準日及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6955-2026-08-10-1511-37n2dy","company_id":"6955","company":"邦睿生技-創","market":"上市","industry":"生技醫療","date":"2026-08-10","time":"15:11:58","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：邦睿生技-創（6955），2026-08-10 15:11，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-08-10-1424-1rlflxj","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"14:24:59","subject":"公告修正本公司114年度股東會年報部份內容","clause":"第53款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-08-10 14:24，「公告修正本公司114年度股東會年報部份內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-08-10-1419-smvay9","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"14:19:35","subject":"本公司115年第二季合併財務報告經董事會決議通過","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-08-10 14:19，「本公司115年第二季合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-08-10-1410-5rh607","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"14:10:25","subject":"公告本公司董事會決議解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-08-10 14:10，「公告本公司董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-08-10-1410-1duskpk","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"14:10:08","subject":"公告本公司115年第二季財務報告業經提報董事會通過","clause":"第31款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-08-10 14:10，「公告本公司115年第二季財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-08-10-1409-1qj44hg","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"14:09:45","subject":"公告本公司財務主管異動","clause":"第8款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-08-10 14:09，「公告本公司財務主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-08-10-1409-l7qirp","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"14:09:16","subject":"公告本公司會計主管異動","clause":"第8款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-08-10 14:09，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-08-10-1408-vxfun9","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-08-10","time":"14:08:43","subject":"公告本公司發言人暨公司治理主管異動","clause":"第8款","fact_date":"2026-08-10","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-08-10 14:08，「公告本公司發言人暨公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}